Advancing novel antidepressants and anxiolytics based on clinically validated mechanisms powered by our Glyph™ platform.

Uniquely designed to enable oral bioavailability, avoid first-pass metabolism and reduce hepatotoxicity and other side effects.

about helping people living with neuropsychiatric disorders.

Seaport Therapeutics
6 Tide Street
Seaport Boston, MA 02210

© 2024 Seaport Therapeutics